Revvity | PKI - 债务利息支出



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 15.77B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


债务利息支出 更改 日
Agilent USD 29M 4M 2026-06
Align Technology USD 6.93M 9.11M 2026-03
Bio Techne USD 3.6M 1.19M 2026-06
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Bruker USD 17.8M 9.7M 2026-06
Celltrion KRW 19B 1.96B 2025-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Danaher USD 107M 44M 2026-06
Dentsply International USD 22M 2M 2026-06
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-06
Edwards Lifesciences USD 30M 5.9M 2026-06
Illumina USD 24M 2M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Laboratory Of America USD 61.1M 6M 2026-06
Medical Developments International AUD 18K 3K 2025-06
Mesa Laboratories USD 3.02M 180K 2024-09
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
OraSure Technologies 1.67M 1.13M 2025-12
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.02M 1.03M 2026-06
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.66M 85K 2026-06
Revvity USD 22.99M 1.73M 2026-06
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Waters USD 55M 13M 2026-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06